Nasal Packing Versus Intravenous Dexmedetomidine in Turbinate Surgeries (NCT05911776) | Clinical Trial Compass
CompletedPhase 4
Nasal Packing Versus Intravenous Dexmedetomidine in Turbinate Surgeries
Egypt60 participantsStarted 2023-06-30
Plain-language summary
Comparing of nasal packing DEX and IV DEX for controlling the intraoperative bleeding after turbinate surgery.
Who can participate
Age range18 Years – 65 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Age 18 to 65 years
* Both sexes
* American Society of Anesthesiologists (ASA) physical status classification I or II.
* Undergo turbinate surgery
Exclusion Criteria:
* Patients with a body mass index \> 30 kg/m2 existing or recent significant disease.
* Contraindications to the use of dexmedetomidine .
* History or presence of a significant disease significant cardiovascular disease risk factors.
* Significant coronary artery disease or any known genetic predisposition.
* History of any kind of drug allergy,
* Drug abuse.
* Clinically significant abnormal findings in physical examination, electrocardiographic (ECG) or laboratory screening.
* Known systemic disease requiring the use of anticoagulants,
* Patients with a history of previous turbinate surgery.